1. Home
  2. HUMA vs MFIN Comparison

HUMA vs MFIN Comparison

Compare HUMA & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • MFIN
  • Stock Information
  • Founded
  • HUMA 2004
  • MFIN 1995
  • Country
  • HUMA United States
  • MFIN United States
  • Employees
  • HUMA N/A
  • MFIN N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • MFIN Finance: Consumer Services
  • Sector
  • HUMA Health Care
  • MFIN Finance
  • Exchange
  • HUMA Nasdaq
  • MFIN Nasdaq
  • Market Cap
  • HUMA 221.8M
  • MFIN 207.3M
  • IPO Year
  • HUMA N/A
  • MFIN 1996
  • Fundamental
  • Price
  • HUMA $2.67
  • MFIN $9.17
  • Analyst Decision
  • HUMA Strong Buy
  • MFIN
  • Analyst Count
  • HUMA 7
  • MFIN 0
  • Target Price
  • HUMA $13.00
  • MFIN N/A
  • AVG Volume (30 Days)
  • HUMA 5.4M
  • MFIN 41.3K
  • Earning Date
  • HUMA 05-13-2025
  • MFIN 07-29-2025
  • Dividend Yield
  • HUMA N/A
  • MFIN 3.60%
  • EPS Growth
  • HUMA N/A
  • MFIN N/A
  • EPS
  • HUMA N/A
  • MFIN 1.60
  • Revenue
  • HUMA $517,000.00
  • MFIN $316,751,000.00
  • Revenue This Year
  • HUMA N/A
  • MFIN N/A
  • Revenue Next Year
  • HUMA $896.45
  • MFIN $5.24
  • P/E Ratio
  • HUMA N/A
  • MFIN $5.73
  • Revenue Growth
  • HUMA N/A
  • MFIN 13.91
  • 52 Week Low
  • HUMA $1.15
  • MFIN $6.48
  • 52 Week High
  • HUMA $9.97
  • MFIN $10.50
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 69.67
  • MFIN 50.42
  • Support Level
  • HUMA $2.41
  • MFIN $9.14
  • Resistance Level
  • HUMA $2.88
  • MFIN $9.48
  • Average True Range (ATR)
  • HUMA 0.30
  • MFIN 0.31
  • MACD
  • HUMA 0.10
  • MFIN -0.02
  • Stochastic Oscillator
  • HUMA 87.43
  • MFIN 44.83

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.

Share on Social Networks: